Silicon Laboratories (SLAB) Reports Q4 Loss, Tops Revenue Estimates

04.02.25 14:15 Uhr

Werte in diesem Artikel
Aktien

141,00 EUR 0,00 EUR 0,00%

Indizes

19.792,0 PKT 99,7 PKT 0,51%

1.854,4 PKT -8,4 PKT -0,45%

Silicon Laboratories (SLAB) came out with a quarterly loss of $0.11 per share in line with the Zacks Consensus Estimate. This compares to loss of $1.19 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this chipmaker would post a loss of $0.21 per share when it actually produced a loss of $0.13, delivering a surprise of 38.10%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Silicon Labs, which belongs to the Zacks Semiconductor - Analog and Mixed industry, posted revenues of $166.25 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.09%. This compares to year-ago revenues of $86.85 million. The company has topped consensus revenue estimates four times over the last four quarters.The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.Silicon Labs shares have added about 8.5% since the beginning of the year versus the S&P 500's gain of 1.9%.What's Next for Silicon Labs?While Silicon Labs has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.Ahead of this earnings release, the estimate revisions trend for Silicon Labs: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.08 on $173.17 million in revenues for the coming quarter and $1.18 on $800.42 million in revenues for the current fiscal year.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Semiconductor - Analog and Mixed is currently in the bottom 18% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.Magnachip (MX), another stock in the same industry, has yet to report results for the quarter ended December 2024.This chip products maker is expected to post quarterly loss of $0.22 per share in its upcoming report, which represents a year-over-year change of -4.8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.Magnachip's revenues are expected to be $61.6 million, up 21.2% from the year-ago quarter.Should You Invest in Silicon Laboratories, Inc. (SLAB)?Before you invest in Silicon Laboratories, Inc. (SLAB), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Silicon Laboratories, Inc. (SLAB): Free Stock Analysis Report Magnachip Semiconductor Corp. (MX): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Silicon Laboratories Inc.

Wer­bung

Analysen zu Silicon Laboratories Inc.

DatumRatingAnalyst
23.07.2019Silicon Laboratories BuyThe Benchmark Company
25.04.2019Silicon Laboratories OutperformCowen and Company, LLC
31.01.2019Silicon Laboratories HoldNeedham & Company, LLC
30.01.2019Silicon Laboratories BuyThe Benchmark Company
18.05.2018Silicon Laboratories OutperformCowen and Company, LLC
DatumRatingAnalyst
23.07.2019Silicon Laboratories BuyThe Benchmark Company
25.04.2019Silicon Laboratories OutperformCowen and Company, LLC
30.01.2019Silicon Laboratories BuyThe Benchmark Company
18.05.2018Silicon Laboratories OutperformCowen and Company, LLC
06.04.2018Silicon Laboratories BuyThe Benchmark Company
DatumRatingAnalyst
31.01.2019Silicon Laboratories HoldNeedham & Company, LLC
27.04.2016Silicon Laboratories NeutralMKM Partners
28.10.2015Silicon Laboratories NeutralMKM Partners
25.09.2015Silicon Laboratories NeutralMKM Partners
30.07.2015Silicon Laboratories Equal WeightBarclays Capital
DatumRatingAnalyst
19.12.2005Silicon Lab sellStifel Nicolaus & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Silicon Laboratories Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"